Protea Biosciences Cash Flow - Quarterly (OTCMKTS:PRGBQ)

Add to My Stocks
$0.01 $0 (0%) PRGBQ stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Protea Biosciences from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Protea Biosciences profits, the balance sheet shows Protea Biosciences debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Protea Biosciences stock analysis shows negative net income cash flow of $-11.36M till 2017 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. Protea Biosciences saw a outflow of $- from investing activities till 2017 Q2.

View and download details of Protea Biosciences cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow------
Net Increase (Decrease) in Assets Liabilities----0.08M--
Cash From (used in) Discontinued Operations------
Other Adjustments Net8.51M4.48M10.28M-0.18M-0.47M3.18M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.01M-0.06M-0.01M--
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments--1.5M1.31M--
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--1.1M--1.68M
Issuance (Repayment) of Debt Securities--0.1M-1.33M1.85M-0.15M-0.11M
Increase (Decrease) in Bank & Other Borrowings1.41M-3.4M--2.98M
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-0.01M--0.35M-0.3M-0.06M-0.3M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.08M-----
Cash & Equivalents at Year End------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our MEDPACE HLDGS financial analysis

Protea Biosciences stock comparison chart provides an easy way to compare the stock price with peers along with details of Protea Biosciences stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Protea Biosciences has cash of $- on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Protea Biosciences stock price.
  • Protea Biosciences decreased its cash from operating activities to $-2.27M till 2017 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $- for PRGBQ stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $2.25M for Protea Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Protea Biosciences Cash Flow

Quarterly Cash Flow Statements For Protea Biosciences Group Inc Peers